Showing results (681-690 of 3,079) with videos related to

Sort By:
Pageof 308
Drug Safety|September 24, 2025
Charting and Sidestepping the Pitfalls of Disproportionality AnalysisMichele Fusaroli, Daniele Sartori, Eugène P van Puijenbroek, et al.
Drug Safety|August 4, 2025
How does the Content and Dissemination of Communications on the Risks of Medicines Affect Prescriber Awareness, Knowledge, and Behaviour: A Systematic ReviewLucy T Perry, Annim Mohammad, Ashleigh Hooimeyer, et al.
Drug Safety|August 5, 2025
Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation StrategiesCeleste L Y Ewig, Yanning Wang, Nicole E Smolinski, et al.
Drug Safety|July 31, 2025
Epidemiology of Thrombotic Thrombocytopenia Syndrome 2011 to 2022: English Sentinel Network Cohort StudiesJosé M Ordóñez-Mena, Debasish Kar, Xuejuan Fan, et al.
Drug Safety|July 31, 2025
Observed Versus Expected Analysis-How Does It Fit in the Pharmacovigilance Toolkit?Lionel Van Holle
Drug Safety|May 9, 2021
Signal Detection in EUROmediCAT: Identification and Evaluation of Medication-Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of ReferenceAlana Cavadino, Lovisa Sandberg, Inger Öhman, et al.
Drug Safety|June 25, 2025
Sex Differences in Electrolyte Disturbances Among Diuretic Users According to Renal Function and AgeNarumi Maida, Shingo Kondo, Naoko Hayashi, et al.
Drug Safety|June 23, 2025
Uncovering Pregnancy Exposures in Pharmacovigilance Case Report Databases: A Comprehensive Evaluation of the VigiBase Pregnancy AlgorithmLovisa Sandberg, Sara Hedfors Vidlin, Levente K-Pápai, et al.
Drug Safety|December 16, 2025
Pharmacovigilance Due Diligence in Drug Development: A Practical Playbook for Risk Identification, Compliance Assessment, and Strategic Decision MakingAshraf Youssef, Tarek A Hammad
Drug Safety|December 4, 2025
Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert ConsensusAnna Fettiplace, Arie Regev, Alexandre Kiazand, et al.
Pageof 308